Pfizer Chips Away At State Claims In Lipitor Antitrust MDL
By Dani Kass · August 22, 2018, 7:47 PM EDT
A New Jersey federal judge has found that state antitrust claims against Pfizer Inc. and Ranbaxy Inc. tied to sales of the blockbuster cholesterol medication Lipitor aren't preempted by federal patent...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login